Molecular predictors of response to pembrolizumab in thymic carcinoma
Yongfeng He, Archana Ramesh, Yuriy Gusev, Krithika Bhuvaneshwar, Giuseppe Giaccone
Abstract
) could be potential predictors for response or resistance to immunotherapy in patients with advanced thymic carcinoma. Our study provides insights into potential predictive markers/pathways to select patients with thymic carcinoma for anti-PD-1 immunotherapy.
Topics & Concepts
PembrolizumabThymic carcinomaCarcinomaOncologyMedicineInternal medicinePsychologyBiologyCancerImmunotherapyChemotherapyMyasthenia Gravis and ThymomaCancer Immunotherapy and BiomarkersPituitary Gland Disorders and Treatments